Literature DB >> 17701122

Conceptual importance of identifying alcoholic liver disease as a lifestyle disease.

Hidekazu Tsukamoto1.   

Abstract

The concept that alcoholic liver disease (ALD) is as a toxic disease does not mirror the exact nature of the disease. ALD should be defined as an alcohol-associated lifestyle disease, the predisposition to which is largely governed by gene-environment interactions, much like other chronic diseases such as diabetes, atherosclerosis, and neurodegenerative diseases. The epidemiology and pathogenesis of ALD need to be re-addressed from this viewpoint. Specifically, the interactions between alcohol and secondary risk factors (high-fat diet, iron, tobacco, medications, female gender) and comorbidities (viral hepatitis, diabetes) are of urgent epidemiological importance. Molecular characterization of the interfaces of these interactions is essential for revelation or acquisition of new pathogenetic, preventive, and therapeutic insights.

Entities:  

Mesh:

Year:  2007        PMID: 17701122     DOI: 10.1007/s00535-007-2075-3

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  49 in total

Review 1.  Alcohol use and hepatitis C.

Authors:  Marion G Peters; Norah A Terrault
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

2.  Per capita alcohol consumption and liver cirrhosis mortality in 14 European countries.

Authors:  M Ramstedt
Journal:  Addiction       Date:  2001-02       Impact factor: 6.526

Review 3.  Regulation of Kupffer cell activity during chronic ethanol exposure: role of adiponectin.

Authors:  Pil-Hoon Park; Varsha Thakur; Michele T Pritchard; Megan R McMullen; Laura E Nagy
Journal:  J Gastroenterol Hepatol       Date:  2006-10       Impact factor: 4.029

4.  Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma.

Authors:  H Kuper; A Tzonou; E Kaklamani; C C Hsieh; P Lagiou; H O Adami; D Trichopoulos; S O Stuver
Journal:  Int J Cancer       Date:  2000-02-15       Impact factor: 7.396

Review 5.  Genetics of alcoholic liver disease and nonalcoholic fatty liver disease.

Authors:  Nimantha Mark Wilfred de Alwis; Christopher Paul Day
Journal:  Semin Liver Dis       Date:  2007-02       Impact factor: 6.115

6.  Risk factors of fibrosis in alcohol-induced liver disease.

Authors:  Bruno Raynard; Axel Balian; David Fallik; Frédérique Capron; Pierre Bedossa; Jean-Claude Chaput; Sylvie Naveau
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

7.  Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S.

Authors:  Jian-Min Yuan; Sugantha Govindarajan; Kazuko Arakawa; Mimi C Yu
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

8.  Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis.

Authors:  T I Sørensen; M Orholm; K D Bentsen; G Høybye; K Eghøje; P Christoffersen
Journal:  Lancet       Date:  1984-08-04       Impact factor: 79.321

9.  Chronic liver diseases for the risk of hepatocellular carcinoma: a case-control study in Japan. Etiologic association of alcohol consumption, cigarette smoking and the development of chronic liver diseases.

Authors:  M Mukaiya; M Nishi; H Miyake; K Hirata
Journal:  Hepatogastroenterology       Date:  1998 Nov-Dec

Review 10.  II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin.

Authors:  R G Thurman
Journal:  Am J Physiol       Date:  1998-10
View more
  10 in total

1.  Single-nucleotide rs738409 polymorphisms in the PNPLA3 gene are strongly associated with alcoholic liver disease in Han Chinese males.

Authors:  Yanfang Zhang; Tongsheng Guo; Funing Yang; Yuanli Mao; Liubing Li; Chenxi Liu; Qiang Sun; Yongzhe Li; Jing Huang
Journal:  Hepatol Int       Date:  2018-08-21       Impact factor: 6.047

2.  Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease.

Authors:  Zoltan Derdak; Charles H Lang; Kristine A Villegas; Ming Tong; Nicholas M Mark; Suzanne M de la Monte; Jack R Wands
Journal:  J Hepatol       Date:  2010-09-06       Impact factor: 25.083

3.  Alcoholic liver disease.

Authors:  Radan Bruha; Karel Dvorak; Jaromir Petrtyl
Journal:  World J Hepatol       Date:  2012-03-27

4.  Alcohol, TLR4-TGF-β antagonism, and liver cancer.

Authors:  Hidekazu Tsukamoto; Lopa Mishra; Keigo Machida
Journal:  Hepatol Int       Date:  2013-12-27       Impact factor: 6.047

5.  Role of free radicals in liver diseases.

Authors:  Pablo Muriel
Journal:  Hepatol Int       Date:  2009-11-26       Impact factor: 6.047

6.  Oats supplementation prevents alcohol-induced gut leakiness in rats by preventing alcohol-induced oxidative tissue damage.

Authors:  Yueming Tang; Christopher B Forsyth; Ali Banan; Jeremy Z Fields; Ali Keshavarzian
Journal:  J Pharmacol Exp Ther       Date:  2009-03-10       Impact factor: 4.030

7.  Hepatic macrophage iron aggravates experimental alcoholic steatohepatitis.

Authors:  Shigang Xiong; Hongyun She; An-Sheng Zhang; Jiaohong Wang; Hasmik Mkrtchyan; Alla Dynnyk; Victor R Gordeuk; Samuel W French; Caroline A Enns; Hidekazu Tsukamoto
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-07-03       Impact factor: 4.052

8.  Risk factors for alcohol-related liver injury in the island population of China: a population-based case-control study.

Authors:  Zhe Shen; You-Ming Li; Chao-Hui Yu; Yi Shen; Lei Xu; Cheng-Fu Xu; Jin-Jin Chen; Hua Ye; Gen-Yun Xu
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

9.  Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis.

Authors:  Christopher B Forsyth; Ashkan Farhadi; Shriram M Jakate; Yueming Tang; Maliha Shaikh; Ali Keshavarzian
Journal:  Alcohol       Date:  2009-03       Impact factor: 2.405

10.  Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4/MyD88/NF-κB signaling pathway.

Authors:  Min Liu; Youwei Xu; Xu Han; Lianhong Yin; Lina Xu; Yan Qi; Yanyan Zhao; Kexin Liu; Jinyong Peng
Journal:  Sci Rep       Date:  2015-12-10       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.